Unigestion Holding SA Boosts Holdings in The Procter & Gamble Company (NYSE:PG)

Unigestion Holding SA boosted its position in shares of The Procter & Gamble Company (NYSE:PGFree Report) by 22.4% in the third quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 272,441 shares of the company’s stock after acquiring an additional 49,947 shares during the quarter. Procter & Gamble accounts for 2.3% of Unigestion Holding SA’s portfolio, making the stock its 7th biggest holding. Unigestion Holding SA’s holdings in Procter & Gamble were worth $47,179,000 at the end of the most recent reporting period.

Several other large investors also recently added to or reduced their stakes in the business. Valued Wealth Advisors LLC grew its position in shares of Procter & Gamble by 51.5% during the second quarter. Valued Wealth Advisors LLC now owns 544 shares of the company’s stock worth $90,000 after purchasing an additional 185 shares in the last quarter. Phoenix Wealth Advisors grew its holdings in Procter & Gamble by 4.9% during the 2nd quarter. Phoenix Wealth Advisors now owns 6,954 shares of the company’s stock valued at $1,147,000 after buying an additional 326 shares in the last quarter. James J. Burns & Company LLC lifted its holdings in shares of Procter & Gamble by 76.6% in the second quarter. James J. Burns & Company LLC now owns 5,472 shares of the company’s stock worth $903,000 after buying an additional 2,373 shares in the last quarter. Meadow Creek Wealth Advisors LLC boosted its position in shares of Procter & Gamble by 4.6% during the second quarter. Meadow Creek Wealth Advisors LLC now owns 9,559 shares of the company’s stock worth $1,576,000 after acquiring an additional 419 shares during the last quarter. Finally, Patrick M Sweeney & Associates Inc. increased its holdings in Procter & Gamble by 4.5% in the 2nd quarter. Patrick M Sweeney & Associates Inc. now owns 5,502 shares of the company’s stock valued at $907,000 after acquiring an additional 236 shares during the last quarter. 65.77% of the stock is currently owned by institutional investors.

Procter & Gamble Stock Up 0.9 %

Shares of NYSE PG opened at $172.38 on Wednesday. The Procter & Gamble Company has a 52-week low of $142.50 and a 52-week high of $180.43. The company has a debt-to-equity ratio of 0.50, a quick ratio of 0.55 and a current ratio of 0.75. The stock has a 50 day moving average price of $170.71 and a 200 day moving average price of $169.44. The firm has a market capitalization of $405.96 billion, a price-to-earnings ratio of 29.72, a PEG ratio of 3.68 and a beta of 0.44.

Procter & Gamble (NYSE:PGGet Free Report) last announced its quarterly earnings results on Friday, October 18th. The company reported $1.93 earnings per share for the quarter, topping the consensus estimate of $1.90 by $0.03. The firm had revenue of $21.74 billion during the quarter, compared to analysts’ expectations of $21.99 billion. Procter & Gamble had a net margin of 17.07% and a return on equity of 33.25%. The company’s revenue was down .6% compared to the same quarter last year. During the same quarter in the prior year, the company earned $1.83 EPS. Sell-side analysts expect that The Procter & Gamble Company will post 6.97 earnings per share for the current year.

Procter & Gamble Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, November 15th. Investors of record on Friday, October 18th were paid a dividend of $1.0065 per share. The ex-dividend date of this dividend was Friday, October 18th. This represents a $4.03 annualized dividend and a dividend yield of 2.34%. Procter & Gamble’s dividend payout ratio (DPR) is presently 69.48%.

Insider Transactions at Procter & Gamble

In other news, insider Susan Street Whaley sold 634 shares of the business’s stock in a transaction on Wednesday, October 2nd. The shares were sold at an average price of $171.65, for a total transaction of $108,826.10. Following the sale, the insider now directly owns 19,341 shares of the company’s stock, valued at $3,319,882.65. The trade was a 3.17 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CEO Jon R. Moeller sold 7,007 shares of the firm’s stock in a transaction on Wednesday, October 2nd. The stock was sold at an average price of $171.65, for a total value of $1,202,751.55. Following the completion of the transaction, the chief executive officer now owns 269,172 shares of the company’s stock, valued at $46,203,373.80. This trade represents a 2.54 % decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders have sold 83,080 shares of company stock valued at $14,629,038. Corporate insiders own 0.18% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research analysts have recently weighed in on PG shares. Hsbc Global Res upgraded Procter & Gamble to a “strong-buy” rating in a research report on Friday, October 4th. JPMorgan Chase & Co. lifted their price objective on Procter & Gamble from $179.00 to $186.00 and gave the stock an “overweight” rating in a research note on Thursday, September 19th. Wells Fargo & Company increased their price objective on shares of Procter & Gamble from $188.00 to $190.00 and gave the company an “overweight” rating in a research report on Friday, November 22nd. Evercore ISI upped their target price on shares of Procter & Gamble from $180.00 to $183.00 and gave the company an “outperform” rating in a research report on Monday, October 21st. Finally, Morgan Stanley lifted their price target on Procter & Gamble from $174.00 to $191.00 and gave the stock an “overweight” rating in a research report on Monday, October 21st. Eight investment analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and two have issued a strong buy rating to the company. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $180.45.

Read Our Latest Analysis on PG

Procter & Gamble Profile

(Free Report)

The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.

Recommended Stories

Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Procter & Gamble Company (NYSE:PGFree Report).

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.